IL1A and rheumatoid arthritis: In the mouse CIA model (a preclinical model of RA), its derivative TIM1c, administered in oral form, showed a similar effect to Etanercept, alleviating RA signs and arthritis, as well as a reduction in inflammatory factors IL-1ß and IL-6, with better anti-inflammatory activity (259).